Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
about
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriersSpecificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopesSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Adoptive T-Cell ImmunotherapyUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsAdoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceImmunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyThe CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation.T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infectionHigh fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.T-cell memory: lessons from Epstein-Barr virus infection in manCD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosisMolecular virology of Epstein-Barr virus.The immunology of Epstein-Barr virus infectionThe Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and eliminationExpansion of a CD28-intermediate subset among CD8 T cells in patients with infectious mononucleosisSequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.Virus and cell RNAs expressed during Epstein-Barr virus replicationA new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisCellular immune responses in transplantation-associated chronic viral infections.Allergen-specific CD8(+) T cells and atopic disease.Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management.Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.
P2860
Q24517035-97B1BC90-8DBF-4FF5-8EE7-F8DAEA89418EQ24541318-554BB695-0D76-463B-9A14-37D6A240CC02Q24792319-16A36D43-EE99-4E56-BB4F-B720E67F71CDQ24814428-656626B3-D0F9-48CF-A303-A94A423F1B7AQ26782845-AA0298F2-E960-4EA1-A5E6-1472FB3F2387Q26823898-78F3D52B-F1AD-465D-B7B3-C082A68C2CACQ27324235-093B10E6-270B-4339-8BB8-CF95E9B8438FQ33289956-D2C50B8C-175B-4821-85CF-9996838D8FAFQ33470219-AE0213C8-1294-4AC0-B6C6-5AA6531DB0D4Q33474804-1A81BD70-583D-41B3-837D-A55DBB471707Q33640163-3B21E07B-7F84-4517-9871-943D2146D1CAQ33658817-A67ECC5F-61D4-493F-8473-F7D576CE80F0Q33713932-7F11A6EF-580C-4B43-B67D-E0B79B27B092Q33719101-8CF05CE9-9EDF-4906-BE4C-A2DD1651CB28Q33824612-D9A30EB4-BD08-4758-B4C7-090CC1A601E6Q33825567-29F6A76A-88EB-4BC4-86AD-FE2206851752Q33835126-EFC2686A-D9CB-4138-A30F-F7941D906E98Q33880339-C80E4D15-E4C3-4198-A642-A3FD4A647C55Q33884942-6890F1DF-1072-48A6-BC7A-8F5E66CBEFE9Q33905235-8D5EA602-73E3-4559-A6C2-0A057C492A55Q33950129-59813426-916B-4A35-9FA4-B4ECB2F15AA6Q34123985-19127036-9C9C-4BAC-9504-592E28967532Q34147153-9F1F5B9A-8B8D-4693-A7DC-6102084FDCD4Q34225554-E82658DB-FBEF-4A58-8F66-A69DF9833054Q34225567-A8BB5DE6-13D0-451A-8260-27B30F9C7D60Q34275895-193D195B-0146-4405-84E0-5C42864BFCD1Q34277034-E4594D49-4C15-40E3-AF29-1127B6F7EC57Q34341657-81EE7DB6-DCD7-4248-A793-748EC704C73EQ34410536-3B84329B-A115-4922-9D19-01FC96FB08D5Q34434702-7BA61190-74AE-4672-8E36-54C304A08222Q34457976-9EB5B10E-EF0D-48EB-A409-88C888061FB8Q34478829-E8933101-C7D9-45FD-8EF1-3FA366C71671Q34671815-985E77E0-14BA-4066-A7CE-FB3F282ECEE5Q34746964-59FC429C-1B40-434C-A444-B07E2C11046CQ34815169-EA7DB923-61A7-494E-B09F-262E9169F569Q34861980-1C98416E-9692-4247-9CA4-EA2F80D61C3BQ35212646-55D1DAC1-B9BF-4551-8DB8-2A0E0D6229D6Q35223805-F274AB9F-CA8F-4276-8938-DA597C1DAF44Q35573295-2BF1FDF2-00B7-4EB0-8A10-CFCF2BC87F6AQ35621782-A7ABD21D-9A82-4440-82B7-9681A3490431
P2860
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Immediate early and early lyti ...... uced cytotoxic T cell response
@ast
Immediate early and early lyti ...... uced cytotoxic T cell response
@en
type
label
Immediate early and early lyti ...... uced cytotoxic T cell response
@ast
Immediate early and early lyti ...... uced cytotoxic T cell response
@en
prefLabel
Immediate early and early lyti ...... uced cytotoxic T cell response
@ast
Immediate early and early lyti ...... uced cytotoxic T cell response
@en
P2093
P2860
P356
P1476
Immediate early and early lyti ...... uced cytotoxic T cell response
@en
P2093
A B Rickinson
M G Kurilla
N E Annels
N M Steven
P2860
P304
P356
10.1084/JEM.185.9.1605
P407
P577
1997-05-01T00:00:00Z